XBiotech Inc

XBITNASDAQ · USD
2.19USD0.00 (+0.46%)
815

XBiotech Inc (XBIT) Covered Calls

No qualifying covered call setups were found for XBIT in the prior session.

Read more

Running XBIT covered calls helps you generate consistent income from XBiotech Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on XBiotech Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best XBIT covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if XBIT stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling XBIT covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given XBiotech Inc covered call is worth writing.

XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation, and True Human COVID-19 therapy for treating the COVID-19 mutant virus.

The company was incorporated in 2005 and is headquartered in Austin, Texas.

Income-focused investors, long-term XBIT holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling XBIT covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best XBiotech Inc covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile91.27% Elevated
  • Market cap (M$)67
  • 52 weeks high-36.34%
  • 52 weeks low4.78%
  • Analyst recommendationHold
    3.00
  • Target price$28.00
    1178.54% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-08-13
  • P/E
  • Future P/E
  • EPS (ttm)-1.48
  • EPS growth next 5 years

As of September 18, 2026

No illustrative rows to display.

As of September 18, 2026

Sell covered calls with the data behind you

Find the best XBIT covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial